Literature DB >> 32324976

COPD at the Time of COVID-19: A COPD Foundation Perspective.

Ruth Tal-Singer1, James D Crapo2,3.   

Abstract

Entities:  

Keywords:  COVID-19; chronic obstructive pulmonary disease; copd; coronavirus

Year:  2020        PMID： 32324976      PMCID： PMC7454024          DOI： 10.15326/jcopdf.7.2.2020.0149

Source DB:  PubMed          Journal:  Chronic Obstr Pulm Dis        ISSN： 2372-952X


× No keyword cloud information.
  9 in total

1.  What to Do When Pulmonary Rehabilitation (PR) Is Unavailable.

Authors:  Judy Corn; Elisha Malanga; Katherine Pruitt
Journal:  Am J Respir Crit Care Med       Date:  2020-06-01       Impact factor: 21.405

Review 2.  Nicotine and the renin-angiotensin system.

Authors:  Joshua M Oakes; Robert M Fuchs; Jason D Gardner; Eric Lazartigues; Xinping Yue
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-08-08       Impact factor: 3.619

3.  Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.

Authors:  Chaomin Wu; Xiaoyan Chen; Yanping Cai; Jia'an Xia; Xing Zhou; Sha Xu; Hanping Huang; Li Zhang; Xia Zhou; Chunling Du; Yuye Zhang; Juan Song; Sijiao Wang; Yencheng Chao; Zeyong Yang; Jie Xu; Xin Zhou; Dechang Chen; Weining Xiong; Lei Xu; Feng Zhou; Jinjun Jiang; Chunxue Bai; Junhua Zheng; Yuanlin Song
Journal:  JAMA Intern Med       Date:  2020-07-01       Impact factor: 21.873

4.  Smoking Upregulates Angiotensin-Converting Enzyme-2 Receptor: A Potential Adhesion Site for Novel Coronavirus SARS-CoV-2 (Covid-19).

Authors:  Samuel James Brake; Kathryn Barnsley; Wenying Lu; Kielan Darcy McAlinden; Mathew Suji Eapen; Sukhwinder Singh Sohal
Journal:  J Clin Med       Date:  2020-03-20       Impact factor: 4.241

5.  Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease.

Authors:  Wei Liu; Zhao-Wu Tao; Lei Wang; Ming-Li Yuan; Kui Liu; Ling Zhou; Shuang Wei; Yan Deng; Jing Liu; Hui-Guo Liu; Ming Yang; Yi Hu
Journal:  Chin Med J (Engl)       Date:  2020-05-05       Impact factor: 2.628

6.  Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury.

Authors:  Clark D Russell; Jonathan E Millar; J Kenneth Baillie
Journal:  Lancet       Date:  2020-02-07       Impact factor: 79.321

7.  Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19).

Authors:  Giuseppe Lippi; Brandon Michael Henry
Journal:  Eur J Intern Med       Date:  2020-03-16       Impact factor: 4.487

8.  The impact of COPD and smoking history on the severity of COVID-19: A systemic review and meta-analysis.

Authors:  Qianwen Zhao; Meng Meng; Rahul Kumar; Yinlian Wu; Jiaofeng Huang; Ningfang Lian; Yunlei Deng; Su Lin
Journal:  J Med Virol       Date:  2020-05-17       Impact factor: 2.327

9.  Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis.

Authors:  Wei-Jie Guan; Wen-Hua Liang; Yi Zhao; Heng-Rui Liang; Zi-Sheng Chen; Yi-Min Li; Xiao-Qing Liu; Ru-Chong Chen; Chun-Li Tang; Tao Wang; Chun-Quan Ou; Li Li; Ping-Yan Chen; Ling Sang; Wei Wang; Jian-Fu Li; Cai-Chen Li; Li-Min Ou; Bo Cheng; Shan Xiong; Zheng-Yi Ni; Jie Xiang; Yu Hu; Lei Liu; Hong Shan; Chun-Liang Lei; Yi-Xiang Peng; Li Wei; Yong Liu; Ya-Hua Hu; Peng Peng; Jian-Ming Wang; Ji-Yang Liu; Zhong Chen; Gang Li; Zhi-Jian Zheng; Shao-Qin Qiu; Jie Luo; Chang-Jiang Ye; Shao-Yong Zhu; Lin-Ling Cheng; Feng Ye; Shi-Yue Li; Jin-Ping Zheng; Nuo-Fu Zhang; Nan-Shan Zhong; Jian-Xing He
Journal:  Eur Respir J       Date:  2020-05-14       Impact factor: 16.671
  9 in total
  4 in total

1.  Development of Respercise® a Digital Application for Standardizing Home Exercise in COPD Clinical Trials.

Authors:  John G Yonchuk; Divya Mohan; Nathan K LeBrasseur; Ashley R George; Sally Singh; Ruth Tal-Singer
Journal:  Chronic Obstr Pulm Dis       Date:  2021-04-27

2.  Increased expression of ACE2, the SARS-CoV-2 entry receptor, in alveolar and bronchial epithelium of smokers and COPD subjects.

Authors:  Merel Jacobs; Hannelore P Van Eeckhoutte; Sara R A Wijnant; Wim Janssens; Guy F Joos; Guy G Brusselle; Ken R Bracke
Journal:  Eur Respir J       Date:  2020-08-20       Impact factor: 16.671

Review 3.  Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease.

Authors:  David M G Halpin; Gerard J Criner; Alberto Papi; Dave Singh; Antonio Anzueto; Fernando J Martinez; Alvar A Agusti; Claus F Vogelmeier
Journal:  Am J Respir Crit Care Med       Date:  2021-01-01       Impact factor: 21.405

Review 4.  Targeting Inflammasome Activation in COVID-19: Delivery of RNA Interference-Based Therapeutic Molecules.

Authors:  Lealem Gedefaw; Sami Ullah; Thomas M H Lee; Shea Ping Yip; Chien-Ling Huang
Journal:  Biomedicines       Date:  2021-12-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.